Nancy Kim, UC San Diego Health (IMAGE)

University of California - San Diego

Nancy Kim, UC San Diego Health

Caption

Nancy Kim (right) and her father both live with hereditary transthyretin amyloidosis. Kim was the first patient in the United States to receive this new drug, which stops progression of the disease.

Credit

Nancy Kim

Usage Restrictions

Use photo credit

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.